✦ LIBER ✦

Effects of oral fixed-dose combinations of telmisartan plus ramipril and losartan plus ramipril in hypertension: A multicenter, prospective, randomized, double-blind, phase iii trial in adult indian patients

✍ Scribed by S.D. Jain; Sangram Biradar; I. Periyandavar; Sanjeet Singh Sodhi; K. Anwaruddin; Ashish Gawde; Vidyagauri Baliga; Kailas Gandewar; Anish Desai

Book ID: 116396242
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 738 KB
Volume: 66
Category: Article
ISSN: 0011-393X
DOI: 10.1016/j.curtheres.2005.12.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a comparative, phase III, 12-

Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension

✍ Akhilesh Sharma; Ananda Bagchi; Satish B. Kinagi; Yogesh Kumar Sharma; Vidyagaur 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Comparison of fixed-dose combinations of

Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: Pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials

✍ Yves Lacourcière; Joel M. Neutel; Helmut Schumacher 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 990 KB

Efficacy and Tolerability of Fimasartan,

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 806 KB

Comparative Efficacy and Safety Profile

Comparative Efficacy and Safety Profile of Amlodipine 5 mg/Losartan 50 mg Fixed-Dose Combination and Amlodipine 10 mg Monotherapy in Hypertensive Patients Who Respond Poorly to Amlodipine 5 mg Monotherapy: An 8-Week, Multicenter, Randomized, Double-Blind Phase III Noninferiority Study

✍ Seok-Min Kang; Jong-Chan Youn; Shung Chull Chae; Chang Gyu Park; Joo Young Yang; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 335 KB

I-COMBINE Study: Assessment of Efficacy

I-COMBINE Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Amlodipine Monotherapy in Hypertensive Patients Uncontrolled With Amlodipine 5 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study

✍ Bobrie, Guillaume 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 666 KB

I-ADD Study: Assessment of Efficacy and

I-ADD Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled With Irbesartan 150 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study

✍ Bobrie, Guillaume 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 592 KB